Human Papillomavirus....Let's help develop a vaccine for a brighter future...
The EVE Study
Join us in investigating a study vaccine against HPV, which can lead to cervical and other cancers.
There are over 100 known variants of HPV. Most lead to mild infections. However, some types of HPV can cause cervical and other cancers.
We are looking for women who:
- 1) are between 16 and 26 years of age
2) have not been previously vaccinated against HPV
You will join The EVE Study for about 12 months. This study will compare the investigational vaccine with one that is already FDA approved. You will receive 3 injections in your arm over 6 months. You will be given either the investigational vaccine or an FDA approved vaccine, Gardisil 9.
The EVE Study is researching an investigational HPV vaccine in women. The study will look at whether the vaccine is safe and helps the body produce antibodies against the different variants of HPV.
HPV infections are very common. Nearly everyone will get HPV at some point in their lives.
- More than 42 million Americans are currently infected with HPV types that cause disease.
- About 13 million Americans, including teens, become infected each year.
HPV is spread through intimate skin-to-skin contact. You can get HPV by having vaginal, anal, or oral sex with someone who has the virus, even if they don’t have signs or symptoms.
Some HPV infections can lead to cancer
Most HPV infections (9 out of 10) go away by themselves within 2 years. But sometimes, HPV infections will last longer and can cause some cancers. HPV infections can cause cancers of the:
- Cervix, vagina, and vulva in women
- Penis in men
- Anus in both women and men
- Back of the throat (called oropharyngeal cancer), including the base of the tongue and tonsils, in both men and women
Every year in the United States, HPV causes about 36,000 cases of cancer in men and women. The EVE Study is enrolling women only